EUDA launches gene-modulating supplement; sending shares up premarket

1 hour ago 1

Shares of EUDA Health Holdings (NASDAQ:EUDA) rose 10% in the premarket trade on Tuesday after the company announced that it has secured exclusive global distribution rights for a next-generation immune health supplement from Singapore biotech, Chemokine Pte. Ltd.
Euda Helixé, the